New Canadian Pharmaceutical Company Introduces Dry Eye Treatment
German technology gives access to an entirely preservative-free treatment that remains sterile 6 months after first use Candorvision is pleased to announce the launch of a new treatment option that can fundamentally change the management of dry eye disease. HyloTM offers features that have never been combined before. Providing immediate, long-lasting relief, Hylo is entirely free of preservatives and phosphates. While other preservative-free products are only available in single-dose vials, Hylo comes in a bottle with a patented German-engineered application system, ensuring sterility for six months after first use. Most products containing preservatives are not recommended for use more than 30 days after opening. "Hylo changes everything," says Dr. Frank Heidemann, president and CEO, Candorvision. "Patients now have access to a truly preservative-free product that remains sterile for six months after first use. This means patients need no longer worry about the potential serious side-effects associated with preservatives, the risks of using a product that has been open more than 30 days, or the drawbacks of single-dose vials. We are very proud to be launching this product in Canada." "Dry eye disease can be very painful if not treated properly. It affects millions of Canadians, so we are always looking for treatment options that will be well-tolerated, convenient and effective. Hylo combines features that eye care specialists and patients have sought for a long time," comments Dr. Michèle Mabon, cornea and anterior segment specialist, Hôpital-Maisonneuve Rosemont, and associate clinical professor at Université de Montréal. There are many triggers for dry-eye disease, such as air conditioning, computer work, hormone changes, certain medications, environmental factors, eye surgery such as Lasik, and eye injuries. Artificial tears with preservatives are associated with undesirable side effects, including allergies, damage to corneal cells and damage to contact lenses.
